High-performance liquid chromatographic assay of trans-(-)-5,5a,6,7,8,9,9a,10-octahydro-6-propylpyrimido[4,5-g] quinolin-2-amine dihydrochloride (LY163502), a potent D-2 agonist, in plasma.
Miller
B J
BJ
Department of Drug Disposition, Eli Lilly and Company, Lilly Corporate Center, Indianapolis 46285.
Tenbarge
J B
JB
Bernstein
J R
JR
Franklin
R B
RB
D000284:Administration, Oral; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D007202:Indicators and Reagents; D007275:Injections, Intravenous; D008297:Male; D011804:Quinolines / Q000097:blood* / Q000493:pharmacokinetics; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects*
D007202:Indicators and Reagents; D011804:Quinolines; D011954:Receptors, Dopamine; C047726:quinelorane